KCT0005731已完成未知
Application of human body to evaluate the effect and safety of the intake of Plantago asiatica Extract from obese on the Improvement of Body Fat.
Bundang Jesaeng Hospital0 个研究点目标入组 90 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 65(Year)（—）
- 性别
- All
入选标准
- •1) Subject who voluntarily agree to participate and signs informed consent form
- •2) Aged more than 19 years and less less than 65 years, women and men
- •3) Those who have a body mass index (BMI) of 25kg/ bb m*2 or more and less than 30kg/m*2
- •4) Those who have waist circumference of more than 90cm for men and 85cm for women
- •5) Those who can follow the diet and exercise guidelines during the intervention period
排除标准
- •1) Those who have taken or are likely to take medications that affect body weight, blood sugar, or lipids within one month of the first visit: appetite suppressants, diuresis, beta-blockers, contraceptives, hormone drugs, TCA agents, laxates, blood glucose depressants, lipid-lowering drugs, antidepressants, antidepressants
- •2) If you have,
- •? Uncontrolled hypertension
- •? Those who have been diagnosed with diabetes or are determined to need treatment, or who have fasting blood glucose level of 180 mg /dL or more
- •? Liver dysfunction or hepatobiliary disease
- •? Renal dysfunction
- •? Hyperthyroidism and hypofunction, Cushing's syndrome
- •? If you have a medical history of severe central nervous system disorder that require hospitalization or medication
- •? Those with severe cerebrovascular disease. However, dizziness If there is no medical history, it may be excluded at the discretion of the researcher.
- •? Malignant tumor, lung disease, musculoskeletal disease, immune system or inflammatory disease
- •? A person who complains of gastrointestinal disorders or severe gastrointestinal symptoms such as heartburn, indigestion or severe constipation.
- •3) Those who have experience in satellite type or ministerial resection surgery, for weight loss.
- •4) Those who have participated in commercial obesity programs or received calorific dietary treatment within three months of their first visit.
- •5) Those who have changed his or her weight by more than 5% within three months of their first visit.
- •6) Those who continue to exercise at high intensity.
- •7) Those who have good quality of his usual diet.
- •8) Those who have continuously consumed dietary supplements or herbal medicines affecting their weight, blood glucose, and lipids within one month of their first visit.
- •9) Those who have hypersensitivity to the test / placebo or ingredients or have experienced severe food allergic.
- •10) Participants in other human application research within 1 month of first visit.
- •11) Pregnant or lactating women or have plant to pregnant.
- •12) If the researcher deems inappropriate to participate in this study.
研究者
相似试验
已完成
不适用
A human study to evaluate the effect and the safety of GUCO on blood triglyceride levelsEndocrine, nutritional and metabolic diseaseKCT0003872Inha University Hospital100
已完成
不适用
A human study to evaluate the safety and effectiveness of nutmeg extract on the exercise performanceKCT0003778Seoul National University100
尚未招募
不适用
A human study to evaluate the safety and effectiveness of HemoHIM on exercise performance and fatigue improvementKCT0004905Seoul National University100
尚未招募
不适用
A human study to evaluate the safety and effectiveness of perilla seed oil on improvement of blood circulation and reducing blood lipid levelEndocrine, nutritional and metabolic diseaseKCT0004197Anydoctorhealthcare80
招募中
不适用
A human study to evaluate the safety and effectiveness of Angelica keiskei and red ginseng extract complex on the exercise performanceKCT0001743Seoul National University60